Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 163

1.

A Case of Hemorrhagic Gastric Metastasis from Hepatocellular Carcinoma Successfully Treated Using Coil Embolization of the Left Gastric Artery.

Imai M, Ishikawa T, Okoshi M, Tomiyoshi K, Kojima Y, Horigome R, Nozawa Y, Sano T, Iwanaga A, Honma T, Nemoto T, Takeda K, Nishikura K, Ishihara N, Yoshida T.

Intern Med. 2019 Apr 17. doi: 10.2169/internalmedicine.2172-18. [Epub ahead of print]

2.

[Unresectable combined hepatocellular-cholangiocellular carcinoma treated with transcatheter arterial chemoembolization and gemcitabine: a case study].

Sano T, Ishikawa T, Imai M, Owaki T, Sato H, Nozawa Y, Iwanaga A, Seki K, Honma T, Yoshida T, Nishikura K, Ishihara N, Kamimura T.

Nihon Shokakibyo Gakkai Zasshi. 2018;115(12):1069-1077. doi: 10.11405/nisshoshi.115.1069. Japanese.

PMID:
30531113
3.

Risk factors increasing blood pressure in Japanese colorectal cancer patients treated with bevacizumab.

Nishihara M, Morikawa N, Yokoyama S, Nishikura K, Yasuhara M, Matsuo H.

Pharmazie. 2018 Nov 1;73(11):671-675. doi: 10.1691/ph.2018.8664.

PMID:
30396388
4.

[A Resected Case of Long-Term Survival of Pancreatic Cancer with Simultaneous Multiple Lung Metastasis with Systemic Chemotherapy].

Umebayashi Y, Fukunari H, Kawai Y, Aoki M, Watanabe A, Saito T, Shitara K, Hayashi T, Nishikura K, Watanabe G, Ajioka Y.

Gan To Kagaku Ryoho. 2018 Feb;45(2):291-293. Japanese.

PMID:
29483424
5.

Factors Influencing the Appearance of Oxaliplatin-Induced Allergy.

Nishihara M, Nishikura K, Morikawa N, Yokoyama S.

Biol Pharm Bull. 2017;40(12):2105-2109. doi: 10.1248/bpb.b17-00400.

6.

Dynamic landscape and regulation of RNA editing in mammals.

Tan MH, Li Q, Shanmugam R, Piskol R, Kohler J, Young AN, Liu KI, Zhang R, Ramaswami G, Ariyoshi K, Gupte A, Keegan LP, George CX, Ramu A, Huang N, Pollina EA, Leeman DS, Rustighi A, Goh YPS; GTEx Consortium; Laboratory, Data Analysis &Coordinating Center (LDACC)—Analysis Working Group; Statistical Methods groups—Analysis Working Group; Enhancing GTEx (eGTEx) groups; NIH Common Fund; NIH/NCI; NIH/NHGRI; NIH/NIMH; NIH/NIDA; Biospecimen Collection Source Site—NDRI; Biospecimen Collection Source Site—RPCI; Biospecimen Core Resource—VARI; Brain Bank Repository—University of Miami Brain Endowment Bank; Leidos Biomedical—Project Management; ELSI Study; Genome Browser Data Integration &Visualization—EBI; Genome Browser Data Integration &Visualization—UCSC Genomics Institute, University of California Santa Cruz, Chawla A, Del Sal G, Peltz G, Brunet A, Conrad DF, Samuel CE, O'Connell MA, Walkley CR, Nishikura K, Li JB.

Nature. 2017 Oct 11;550(7675):249-254. doi: 10.1038/nature24041.

7.

Oesophageal cancer: RNA editing of SLC22A3 mRNAs: causative relevance to familial ESCC?

Nishikura K.

Nat Rev Gastroenterol Hepatol. 2017 Oct;14(10):569-570. doi: 10.1038/nrgastro.2017.102. Epub 2017 Jul 26. No abstract available.

8.

ADAR1 controls apoptosis of stressed cells by inhibiting Staufen1-mediated mRNA decay.

Sakurai M, Shiromoto Y, Ota H, Song C, Kossenkov AV, Wickramasinghe J, Showe LC, Skordalakes E, Tang HY, Speicher DW, Nishikura K.

Nat Struct Mol Biol. 2017 Jun;24(6):534-543. doi: 10.1038/nsmb.3403. Epub 2017 Apr 24.

9.

[Three Cases of Long-Term Survival in Colon Cancer with Postoperative Peritoneal Recurrence].

Nakao K, Fukunari H, Yamamoto Y, Kanemoto E, Shitara K, Hayashi T, Nishikura K, Watanabe G, Ajioka Y.

Gan To Kagaku Ryoho. 2016 Nov;43(12):1626-1628. Japanese.

PMID:
28133079
10.

Re-evaluation of Phenotypic Expression in Differentiated-type Early Adenocarcinoma of the Stomach.

Hayakawa M, Nishikura K, Ajioka Y, Aoyagi Y, Terai S.

Pathol Int. 2017 Mar;67(3):131-140. doi: 10.1111/pin.12506. Epub 2017 Jan 15.

PMID:
28088838
11.

Functions of the RNA Editing Enzyme ADAR1 and Their Relevance to Human Diseases.

Song C, Sakurai M, Shiromoto Y, Nishikura K.

Genes (Basel). 2016 Dec 17;7(12). pii: E129. doi: 10.3390/genes7120129. Review.

12.

CAPS1 RNA Editing Promotes Dense Core Vesicle Exocytosis.

Miyake K, Ohta T, Nakayama H, Doe N, Terao Y, Oiki E, Nagatomo I, Yamashita Y, Abe T, Nishikura K, Kumanogoh A, Hashimoto K, Kawahara Y.

Cell Rep. 2016 Nov 15;17(8):2004-2014. doi: 10.1016/j.celrep.2016.10.073.

13.

The mRNA-edited form of GABRA3 suppresses GABRA3-mediated Akt activation and breast cancer metastasis.

Gumireddy K, Li A, Kossenkov AV, Sakurai M, Yan J, Li Y, Xu H, Wang J, Zhang PJ, Zhang L, Showe LC, Nishikura K, Huang Q.

Nat Commun. 2016 Feb 12;7:10715. doi: 10.1038/ncomms10715.

14.

A-to-I editing of coding and non-coding RNAs by ADARs.

Nishikura K.

Nat Rev Mol Cell Biol. 2016 Feb;17(2):83-96. doi: 10.1038/nrm.2015.4. Epub 2015 Dec 9. Review.

15.

Assessment of gastric phenotypes using magnifying narrow-band imaging for differentiation of gastric carcinomas from adenomas.

Kobayashi M, Hashimoto S, Nishikura K, Mizuno K, Takeuchi M, Ajioka Y.

Gastroenterol Res Pract. 2014;2014:274301. doi: 10.1155/2014/274301. Epub 2014 Oct 13.

16.

Enhancement of alcohol drinking in mice depends on alterations in RNA editing of serotonin 2C receptors.

Watanabe Y, Yoshimoto K, Tatebe H, Kita M, Nishikura K, Kimura M, Tanaka M.

Int J Neuropsychopharmacol. 2014 May;17(5):739-51. doi: 10.1017/S1461145713001545. Epub 2013 Dec 17.

17.

Adenosine-to-inosine RNA editing and human disease.

Slotkin W, Nishikura K.

Genome Med. 2013 Nov 29;5(11):105. doi: 10.1186/gm508. eCollection 2013. Review.

18.

Antagonistic and stimulative roles of ADAR1 in RNA silencing.

Nishikura K, Sakurai M, Ariyoshi K, Ota H.

RNA Biol. 2013 Aug;10(8):1240-7. doi: 10.4161/rna.25947. Epub 2013 Jul 30.

19.

Human endonuclease V is a ribonuclease specific for inosine-containing RNA.

Morita Y, Shibutani T, Nakanishi N, Nishikura K, Iwai S, Kuraoka I.

Nat Commun. 2013;4:2273. doi: 10.1038/ncomms3273.

20.

Mucin phenotype expression of gastric neuroendocrine neoplasms: analysis of histopathology and carcinogenesis.

Domori K, Nishikura K, Ajioka Y, Aoyagi Y.

Gastric Cancer. 2014 Apr;17(2):263-72. doi: 10.1007/s10120-013-0281-7. Epub 2013 Jul 5.

PMID:
23828549
21.

ADAR1 forms a complex with Dicer to promote microRNA processing and RNA-induced gene silencing.

Ota H, Sakurai M, Gupta R, Valente L, Wulff BE, Ariyoshi K, Iizasa H, Davuluri RV, Nishikura K.

Cell. 2013 Apr 25;153(3):575-89. doi: 10.1016/j.cell.2013.03.024.

22.

Magnifying narrow-band imaging of surface maturation in early differentiated-type gastric cancers after Helicobacter pylori eradication.

Kobayashi M, Hashimoto S, Nishikura K, Mizuno K, Takeuchi M, Sato Y, Ajioka Y, Aoyagi Y.

J Gastroenterol. 2013 Dec;48(12):1332-42. doi: 10.1007/s00535-013-0764-7. Epub 2013 Feb 19.

PMID:
23420575
23.

ADAR1 protein induces adenosine-targeted DNA mutations in senescent Bcl6 gene-deficient cells.

Tsuruoka N, Arima M, Yoshida N, Okada S, Sakamoto A, Hatano M, Satake H, Arguni E, Wang JY, Yang JH, Nishikura K, Sekiya S, Shozu M, Tokuhisa T.

J Biol Chem. 2013 Jan 11;288(2):826-36. doi: 10.1074/jbc.M112.365718. Epub 2012 Dec 3.

24.

A-to-I editing of protein coding and noncoding RNAs.

Mallela A, Nishikura K.

Crit Rev Biochem Mol Biol. 2012 Nov-Dec;47(6):493-501. doi: 10.3109/10409238.2012.714350. Epub 2012 Sep 18. Review.

PMID:
22988838
25.

Re-evaluation of phenotypic expression in undifferentiated-type early gastric adenocarcinomas using mucin core protein and CDX2.

Ikarashi S, Nishikura K, Ajioka Y, Aoyagi Y.

Gastric Cancer. 2013 Apr;16(2):208-19. doi: 10.1007/s10120-012-0172-3. Epub 2012 Jul 25.

PMID:
22829163
26.

Alpha-methylacyl-coenzyme A racemase expression in neuroendocrine neoplasms of the stomach.

Annenkov A, Nishikura K, Domori K, Ajioka Y.

Virchows Arch. 2012 Aug;461(2):169-75. doi: 10.1007/s00428-012-1272-5. Epub 2012 Jul 11.

27.

Relationship between alpha-methylacyl-coenzyme A racemase expression and mucin phenotype in gastric cancer.

Nozawa Y, Nishikura K, Ajioka Y, Aoyagi Y.

Hum Pathol. 2012 Jun;43(6):878-87. doi: 10.1016/j.humpath.2011.07.017. Epub 2011 Nov 10.

PMID:
22078291
28.

Secondary resistance to imatinib mesylate 70 months after initiation of therapy in a patient with a metastatic gastric gastrointestinal stromal tumor.

Tatsuda K, Kanda T, Ishikawa T, Hirota S, Nishikura K, Yajima K, Kosugi SI, Hatakeyama K.

Clin J Gastroenterol. 2011 Aug;4(4):218-222. doi: 10.1007/s12328-011-0234-9. Epub 2011 Jul 5.

PMID:
26189523
29.

Modulation of microRNA expression and function by ADARs.

Wulff BE, Nishikura K.

Curr Top Microbiol Immunol. 2012;353:91-109. doi: 10.1007/82_2011_151. Review.

PMID:
21761289
30.

Elucidating the inosinome: global approaches to adenosine-to-inosine RNA editing.

Wulff BE, Sakurai M, Nishikura K.

Nat Rev Genet. 2011 Feb;12(2):81-5. doi: 10.1038/nrg2915. Epub 2010 Dec 21. Review.

31.

Substitutional A-to-I RNA editing.

Wulff BE, Nishikura K.

Wiley Interdiscip Rev RNA. 2010 Jul-Aug;1(1):90-101. doi: 10.1002/wrna.10. Review.

32.

Adenosine-to-inosine RNA editing.

Zinshteyn B, Nishikura K.

Wiley Interdiscip Rev Syst Biol Med. 2009 Sep-Oct;1(2):202-209. doi: 10.1002/wsbm.10. Review.

33.

Editing of Epstein-Barr virus-encoded BART6 microRNAs controls their dicer targeting and consequently affects viral latency.

Iizasa H, Wulff BE, Alla NR, Maragkakis M, Megraw M, Hatzigeorgiou A, Iwakiri D, Takada K, Wiedmer A, Showe L, Lieberman P, Nishikura K.

J Biol Chem. 2010 Oct 22;285(43):33358-70. doi: 10.1074/jbc.M110.138362. Epub 2010 Aug 17.

34.

Functional relevance of serotonin 2C receptor mRNA editing in antidepressant- and anxiety-like behaviors.

Mombereau C, Kawahara Y, Gundersen BB, Nishikura K, Blendy JA.

Neuropharmacology. 2010 Nov;59(6):468-73. doi: 10.1016/j.neuropharm.2010.06.009. Epub 2010 Jul 17.

35.

Functions and regulation of RNA editing by ADAR deaminases.

Nishikura K.

Annu Rev Biochem. 2010;79:321-49. doi: 10.1146/annurev-biochem-060208-105251. Review.

36.

[Regulation of the miRNA function by RNA editing].

Kawahara Y, Nishikura K.

Tanpakushitsu Kakusan Koso. 2009 Jul;54(9):1133-40. Review. Japanese. No abstract available.

PMID:
19588876
37.

A case of a choledochal cyst associated with a lymphatic infiltration of a hyperplastic gallbladder epithelium.

Hirayama Y, Kubota M, Hasegawa G, Okuyama N, Ohtaki M, Kobayashi K, Tsukada M, Sato K, Nishikura K, Naito M, Ajioka Y.

J Pediatr Surg. 2009 Apr;44(4):831-5. doi: 10.1016/j.jpedsurg.2008.11.006.

PMID:
19361649
38.

A new function for the RNA-editing enzyme ADAR1.

Iizasa H, Nishikura K.

Nat Immunol. 2009 Jan;10(1):16-8. doi: 10.1038/ni0109-16.

39.

Dysregulated editing of serotonin 2C receptor mRNAs results in energy dissipation and loss of fat mass.

Kawahara Y, Grimberg A, Teegarden S, Mombereau C, Liu S, Bale TL, Blendy JA, Nishikura K.

J Neurosci. 2008 Nov 26;28(48):12834-44. doi: 10.1523/JNEUROSCI.3896-08.2008.

40.

Frequency and fate of microRNA editing in human brain.

Kawahara Y, Megraw M, Kreider E, Iizasa H, Valente L, Hatzigeorgiou AG, Nishikura K.

Nucleic Acids Res. 2008 Sep;36(16):5270-80. doi: 10.1093/nar/gkn479. Epub 2008 Aug 6.

41.

Regulation of innate immune responses by DAI (DLM-1/ZBP1) and other DNA-sensing molecules.

Wang Z, Choi MK, Ban T, Yanai H, Negishi H, Lu Y, Tamura T, Takaoka A, Nishikura K, Taniguchi T.

Proc Natl Acad Sci U S A. 2008 Apr 8;105(14):5477-82. doi: 10.1073/pnas.0801295105. Epub 2008 Mar 28.

42.

A case of biatrial multiple myxomas with glandular structure.

Namura O, Saitoh M, Moro H, Watanabe H, Sogawa M, Nishikura K, Hayashi J.

Ann Thorac Cardiovasc Surg. 2007 Dec;13(6):423-7.

PMID:
18292730
43.

Congenital left brachiocephalic vein and superior vena cava aneurysms in an infant: final update with autopsy findings.

Nitta A, Nishikura K, Fukuda H, Yoshihara S, Hirao J, Arisaka O, Matsuda H.

J Pediatr. 2008 Mar;152(3):445-6. doi: 10.1016/j.jpeds.2007.10.037. No abstract available.

PMID:
18280863
44.

Genetic changes of p53, K-ras, and microsatellite instability in gallbladder carcinoma in high-incidence areas of Japan and Hungary.

Nagahashi M, Ajioka Y, Lang I, Szentirmay Z, Kasler M, Nakadaira H, Yokoyama N, Watanabe G, Nishikura K, Wakai T, Shirai Y, Hatakeyama K, Yamamoto M.

World J Gastroenterol. 2008 Jan 7;14(1):70-5.

45.

Establishment and characterization of monoclonal and polyclonal antibodies against human intestinal fatty acid-binding protein (I-FABP) using synthetic regional peptides and recombinant I-FABP.

Kajiura S, Yashiki T, Funaoka H, Ohkaru Y, Nishikura K, Kanda T, Ajioka Y, Igarashi M, Hatakeyama K, Fujii H.

J Immunoassay Immunochem. 2008;29(1):19-41.

PMID:
18080878
46.

Effect of loss of heterozygosity of the c-kit gene on prognosis after hepatectomy for metastatic liver gastrointestinal stromal tumors.

Kikuchi H, Yamamoto M, Hiramatsu Y, Baba M, Ohta M, Kamiya K, Tanaka T, Suzuki S, Sugimura H, Kitagawa M, Kanai T, Kitayama Y, Kanda T, Nishikura K, Konno H.

Cancer Sci. 2007 Nov;98(11):1734-9.

47.

Mucin expression, p53 overexpression, and peritumoral lymphocytic infiltration of advanced colorectal carcinoma with mucus component: is mucinous carcinoma a distinct histological entity?

Tozawa E, Ajioka Y, Watanabe H, Nishikura K, Mukai G, Suda T, Kanoh T, Hatakeyama K.

Pathol Res Pract. 2007;203(8):567-74.

PMID:
17679024
48.

Two cases of gastrointestinal stromal tumor of the stomach with lymph node metastasis.

Sato T, Kanda T, Nishikura K, Hirota S, Hashimoto K, Nahagawa S, Ohashi M, Hatakeyama K.

Hepatogastroenterology. 2007 Jun;54(76):1057-60.

PMID:
17629038
49.

RNA editing of the microRNA-151 precursor blocks cleavage by the Dicer-TRBP complex.

Kawahara Y, Zinshteyn B, Chendrimada TP, Shiekhattar R, Nishikura K.

EMBO Rep. 2007 Aug;8(8):763-9. Epub 2007 Jun 22.

Supplemental Content

Loading ...
Support Center